J. Joseph Larosa's most recent trade in Regeneron Pharmaceuticals, Inc. was a trade of 702 Common Stock done at an average price of $730.8 . Disclosure was reported to the exchange on Dec. 16, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Regeneron Pharma | J. Joseph Larosa | EVP General Counsel and Secret | Payment of exercise price or tax liability using portion of securities received from the company at price $ 730.81 per share. | 16 Dec 2024 | 702 | 30,075 (0%) | 0% | 730.8 | 513,029 | Common Stock |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2024 | 8,981 | 8,981 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2024 | 2,332 | 31,269 (0%) | 0% | 0 | Common Stock | |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Payment of exercise price or tax liability using portion of securities received from the company at price $ 787.00 per share. | 06 Dec 2024 | 492 | 30,777 (0%) | 0% | 787 | 387,204 | Common Stock |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Sale of securities on an exchange or to another person at price $ 1088.95 per share. | 11 Jul 2024 | 1,866 | 37,937 (0%) | 0% | 1089.0 | 2,031,981 | Common Stock |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2024 | 14,450 | 14,450 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Exercise or conversion of derivative security received from the company (such as an option) at price $ 555.67 per share. | 24 Jun 2024 | 14,450 | 50,887 (0%) | 0% | 555.7 | 8,029,432 | Common Stock |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1060.13 per share. | 24 Jun 2024 | 11,084 | 39,803 (0%) | 0% | 1060.1 | 11,750,481 | Common Stock |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Jun 2024 | 1,608 | 0 (0%) | 0% | 0 | Common Stock | |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Sale of securities on an exchange or to another person at price $ 994.90 per share. | 21 May 2024 | 1,865 | 34,678 (0%) | 0% | 994.9 | 1,855,489 | Common Stock |
| Regeneron Pharma | J. Larosa Joseph | EVP General Counsel and Secret | Sale of securities on an exchange or to another person at price $ 990.00 per share. | 26 Feb 2024 | 1,000 | 36,543 (0%) | 0% | 990 | 990,000 | Common Stock |
| Regeneron Pharma | Larosa J. Joseph | EVP General Counsel and Secret | Sale of securities on an exchange or to another person at price $ 967.65 per share. | 22 Feb 2024 | 1,000 | 37,543 (0%) | 0% | 967.7 | 967,650 | Common Stock |
| Regeneron Pharma | Larosa Joseph J. | EVP General Counsel and Secret | Sale of securities on an exchange or to another person at price $ 950.00 per share. | 07 Feb 2024 | 1,000 | 38,543 (0%) | 0% | 950 | 950,000 | Common Stock |
| Regeneron Pharma | Larosa Joseph J. | EVP General Counsel and Secret | Exercise or conversion of derivative security received from the company (such as an option) at price $ 399.66 per share. | 03 Jan 2024 | 34,000 | 64,036 (0%) | 0% | 399.7 | 13,588,440 | Common Stock |
| Regeneron Pharma | Larosa Joseph J. | EVP General Counsel and Secret | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2024 | 34,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Payment of exercise price or tax liability using portion of securities received from the company at price $ 912.30 per share. | 03 Jan 2024 | 24,493 | 39,543 (0%) | 0% | 912.3 | 22,344,964 | Common Stock |
| Regeneron Pharma | J. Larosa Joseph | EVP General Counsel and Secret | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2023 | 7,649 | 7,649 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | J. Larosa Joseph | EVP General Counsel and Secret | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2023 | 2,133 | 30,705 (0%) | 0% | 0 | Common Stock | |
| Regeneron Pharma | Larosa J. Joseph | EVP General Counsel and Secret | Payment of exercise price or tax liability using portion of securities received from the company at price $ 843.79 per share. | 08 Dec 2023 | 852 | 28,572 (0%) | 0% | 843.8 | 718,909 | Common Stock |
| Regeneron Pharma | Joseph Larosa J. | EVP General Counsel and Secret | Payment of exercise price or tax liability using portion of securities received from the company at price $ 844.09 per share. | 08 Dec 2023 | 669 | 30,036 (0%) | 0% | 844.1 | 564,696 | Common Stock |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Mar 2023 | 10,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Exercise or conversion of derivative security received from the company (such as an option) at price $ 270.43 per share. | 23 Mar 2023 | 10,000 | 34,213 (0%) | 0% | 270.4 | 2,704,300 | Common Stock |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Payment of exercise price or tax liability using portion of securities received from the company at price $ 801.59 per share. | 23 Mar 2023 | 6,742 | 27,471 (0%) | 0% | 801.6 | 5,404,320 | Common Stock |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Mar 2023 | 1,006 | 0 (0%) | 0% | 0 | Common Stock | |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2022 | 10,159 | 10,159 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2022 | 2,752 | 23,110 (0%) | 0% | 0 | Common Stock | |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Payment of exercise price or tax liability using portion of securities received from the company at price $ 753.28 per share. | 09 Dec 2022 | 492 | 20,358 (0%) | 0% | 753.3 | 370,614 | Common Stock |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Exercise or conversion of derivative security received from the company (such as an option) at price $ 270.43 per share. | 09 Sep 2022 | 30,000 | 41,580 (0%) | 0% | 270.4 | 8,112,900 | Common Stock |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2022 | 30,000 | 10,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Payment of exercise price or tax liability using portion of securities received from the company at price $ 730.96 per share. | 09 Sep 2022 | 20,730 | 20,850 (0%) | 0% | 731.0 | 15,152,801 | Common Stock |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Sale of securities on an exchange or to another person at price $ 721.10 per share. | 07 Apr 2022 | 5,114 | 16,900 (0%) | 0% | 721.1 | 3,687,705 | Common Stock |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Sale of securities on an exchange or to another person at price $ 688.59 per share. | 01 Apr 2022 | 799 | 24,906 (0%) | 0% | 688.6 | 550,183 | Common Stock |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Sale of securities on an exchange or to another person at price $ 691.44 per share. | 01 Apr 2022 | 641 | 23,797 (0%) | 0% | 691.4 | 443,213 | Common Stock |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Sale of securities on an exchange or to another person at price $ 693.92 per share. | 01 Apr 2022 | 567 | 23,035 (0%) | 0% | 693.9 | 393,453 | Common Stock |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Sale of securities on an exchange or to another person at price $ 686.26 per share. | 01 Apr 2022 | 557 | 26,202 (0%) | 0% | 686.3 | 382,247 | Common Stock |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Sale of securities on an exchange or to another person at price $ 687.41 per share. | 01 Apr 2022 | 497 | 25,705 (0%) | 0% | 687.4 | 341,643 | Common Stock |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Sale of securities on an exchange or to another person at price $ 685.71 per share. | 01 Apr 2022 | 369 | 26,759 (0%) | 0% | 685.7 | 253,027 | Common Stock |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Sale of securities on an exchange or to another person at price $ 695.36 per share. | 01 Apr 2022 | 305 | 22,471 (0%) | 0% | 695.4 | 212,085 | Common Stock |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Sale of securities on an exchange or to another person at price $ 694.56 per share. | 01 Apr 2022 | 259 | 22,776 (0%) | 0% | 694.6 | 179,891 | Common Stock |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Sale of securities on an exchange or to another person at price $ 696.54 per share. | 01 Apr 2022 | 254 | 22,217 (0%) | 0% | 696.5 | 176,921 | Common Stock |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Sale of securities on an exchange or to another person at price $ 690.51 per share. | 01 Apr 2022 | 250 | 24,438 (0%) | 0% | 690.5 | 172,628 | Common Stock |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Sale of securities on an exchange or to another person at price $ 689.43 per share. | 01 Apr 2022 | 218 | 24,688 (0%) | 0% | 689.4 | 150,296 | Common Stock |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Sale of securities on an exchange or to another person at price $ 692.54 per share. | 01 Apr 2022 | 195 | 23,602 (0%) | 0% | 692.5 | 135,045 | Common Stock |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Sale of securities on an exchange or to another person at price $ 698.26 per share. | 01 Apr 2022 | 124 | 22,029 (0%) | 0% | 698.3 | 86,584 | Common Stock |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Sale of securities on an exchange or to another person at price $ 697.34 per share. | 01 Apr 2022 | 64 | 22,153 (0%) | 0% | 697.3 | 44,630 | Common Stock |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Sale of securities on an exchange or to another person at price $ 701.80 per share. | 01 Apr 2022 | 15 | 22,014 (0%) | 0% | 701.8 | 10,527 | Common Stock |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Payment of exercise price or tax liability using portion of securities received from the company at price $ 664.34 per share. | 11 Dec 2021 | 697 | 26,051 (0%) | 0% | 664.3 | 463,045 | Common Stock |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Exercise or conversion of derivative security received from the company (such as an option) at price $ 179.13 per share. | 08 Dec 2021 | 30,000 | 46,520 (0%) | 0% | 179.1 | 5,373,900 | Common Stock |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2021 | 30,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Payment of exercise price or tax liability using portion of securities received from the company at price $ 657.11 per share. | 08 Dec 2021 | 19,772 | 26,748 (0%) | 0% | 657.1 | 12,992,379 | Common Stock |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2021 | 14,253 | 14,253 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2021 | 3,338 | 16,520 (0%) | 0% | 0 | Common Stock | |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Exercise or conversion of derivative security received from the company (such as an option) at price $ 179.13 per share. | 20 Aug 2021 | 10,000 | 23,182 (0%) | 0% | 179.1 | 1,791,300 | Common Stock |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Aug 2021 | 10,000 | 30,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Payment of exercise price or tax liability using portion of securities received from the company at price $ 664.85 per share. | 20 Aug 2021 | 6,575 | 16,607 (0%) | 0% | 664.9 | 4,371,389 | Common Stock |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Sale of securities on an exchange or to another person at price $ 661.80 per share. | 20 Aug 2021 | 3,383 | 13,224 (0%) | 0% | 661.8 | 2,238,869 | Common Stock |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Sale of securities on an exchange or to another person at price $ 665.39 per share. | 20 Aug 2021 | 41 | 13,183 (0%) | 0% | 665.4 | 27,281 | Common Stock |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Sale of securities on an exchange or to another person at price $ 666.00 per share. | 20 Aug 2021 | 1 | 13,182 (0%) | 0% | 666 | 666 | Common Stock |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jul 2021 | 10,000 | 40,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Exercise or conversion of derivative security received from the company (such as an option) at price $ 179.13 per share. | 02 Jul 2021 | 10,000 | 23,182 (0%) | 0% | 179.1 | 1,791,300 | Common Stock |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Payment of exercise price or tax liability using portion of securities received from the company at price $ 582.20 per share. | 02 Jul 2021 | 6,602 | 16,580 (0%) | 0% | 582.2 | 3,843,684 | Common Stock |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Sale of securities on an exchange or to another person at price $ 580.00 per share. | 02 Jul 2021 | 3,398 | 13,182 (0%) | 0% | 580 | 1,970,840 | Common Stock |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2020 | 19,950 | 19,950 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2020 | 1,930 | 16,368 (0%) | 0% | 0 | Common Stock | |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Aug 2020 | 6,000 | 4,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Exercise or conversion of derivative security received from the company (such as an option) at price $ 52.03 per share. | 27 Aug 2020 | 6,000 | 20,438 (0%) | 0% | 52.0 | 312,180 | Common Stock |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Sale of securities on an exchange or to another person at price $ 615.04 per share. | 27 Aug 2020 | 4,672 | 14,438 (0%) | 0% | 615.0 | 2,873,467 | Common Stock |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Aug 2020 | 4,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Exercise or conversion of derivative security received from the company (such as an option) at price $ 52.03 per share. | 27 Aug 2020 | 4,000 | 21,241 (0%) | 0% | 52.0 | 208,120 | Common Stock |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Payment of exercise price or tax liability using portion of securities received from the company at price $ 614.87 per share. | 27 Aug 2020 | 3,197 | 17,241 (0%) | 0% | 614.9 | 1,965,739 | Common Stock |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Payment of exercise price or tax liability using portion of securities received from the company at price $ 614.87 per share. | 27 Aug 2020 | 2,131 | 19,110 (0%) | 0% | 614.9 | 1,310,288 | Common Stock |